Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07220174Not ApplicableNot Yet Recruiting

Use of GI Genius™ XR Software in Virtual Reality Headset During Routine Colonoscopy

Role: lead

NCT06216405Not ApplicableCompleted

Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection

Role: collaborator

NCT04589078Completed

Polyp REcognition Assisted by a Device Interactive Characterization Tool - The PREDICT Study

Role: lead

NCT03954548Not ApplicableCompleted

CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.

Role: lead

All 4 trials loaded